The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business.
Leslie Walker
Leslie is a senior reporter and producer for Tradeoffs covering a wide range of health policy issues including prescription drugs and Medicare. Her story, “Inside Big Health Insurers’ Side Hustle,” was awarded first place in audio reporting by the Association of Health Care Journalists and her work has been featured on Marketplace, NPR and STAT News. Before Tradeoffs, Leslie worked as a freelance writer and editor, in nonprofit communications, and at a health care social enterprise. She lives in San Francisco.
Posted inHealth Technology
‘We Can’t Afford All These Humans’: A Doctor’s Take on AI in Health Care
We talk with physician and writer Bob Wachter about why he’s cautiously optimistic that artificial intelligence will usher in a ‘golden age’ of medicine — and the questions he still has about these powerful new tools.
Posted inMental Health
A Better Way to Care for Older Adults with Opioid Addiction
How one addiction clinic in Baltimore has found success combining addiction care with support for the many other health problems older Americans often face.
Posted inInsurance
Rising Costs, Fewer Choices: What’s Up with Medicare Drug Plans?
Facing mounting financial pressures, insurance companies are changing the prescription drug coverage available to many consumers in Medicare Part D.
Posted inCost of Care
What Would Actually Lower Drug Prices in America? Experts Weigh In
Some of America’s top scholars on prescription drug pricing outline steps the Trump administration could take to make medicines more affordable.
Posted inCost of Care
Will Trump’s Prescription Drug Deals Really Lower Prices?
Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.
Posted inInsurance
How States Are Reckoning with Republican Health Reforms
It’s been 90 days since Congress passed Trump’s megabill slashing health care spending and reshaping the Medicaid program. States are already knee-deep in dealing with the fallout.
Posted inInsurance
A Closer Look at a Widely Despised Health Insurance Policy
Every year, millions of people’s medical care runs into the roadblock known as prior authorization, which requires a patient’s health insurer to sign off before chemotherapy, surgery or countless other services can proceed. Who does this often onerous process help, who does it hurt and how could it work better for everyone?
Posted inMental Health
This Federal Experiment Is Pouring Money into Mental Hospitals. Will It Work?
As states struggle to meet the needs of people with serious mental illness, some are signing on to a federal pilot project that’s pouring new funding into institutional care.
Posted inInsurance
Former North Carolina Health Secretary Sees Hard Road Ahead for States
Sweeping federal reforms force North Carolina and other states to make tough decisions about Medicaid coverage, costs and eligibility under mounting budget pressure.